AVORO CAPITAL ADVISORS LLC 13D and 13G filings for Krystal Biotech, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 09:25 am Purchase | 2023-12-31 | 13G | Krystal Biotech, Inc. KRYS | AVORO CAPITAL ADVISORS LLC | 2,565,555 9.100% | 1,155,555 (+81.95%) | Filing |
| 2023-02-14 09:33 am Purchase | 2022-12-31 | 13G | Krystal Biotech, Inc. KRYS | AVORO CAPITAL ADVISORS LLC | 1,410,000 5.500% | 1,410,000 (New Position) | Filing |